Aug 5, 2024 · Nexletol (bempedoic acid) is an oral pill for high cholesterol that may be used to reduce the risk of heart attacks and other heart problems in adults with heart disease or at high risk OR lower LDL ("bad") cholesterol levels in adults with high cholesterol.

NEXLETOL includes symptoms of the common cold or flu-like symptoms, muscle spasms, back pain, stomach pain, bronchitis, pain in shoulder, legs, or arms, anemia and increased liver enzymes.

Jan 23, 2022 · Nexletol is a prescription drug used in adults with heterozygous familial hypercholesterolemia (HeFH) or a type of cardiovascular (heart or blood vessel) disease.

Jun 16, 2024 · Nexletol (bempedoic acid) is commonly used for the following conditions. To lower the risk of heart attack and certain heart procedures like stent placement or bypass surgery in people with heart...

Bempedoic acid, sold under the brand name Nexletol among others, is a medication for the treatment of hypercholesterolemia (high blood cholesterol levels). [2][3] The most common side effects include hyperuricemia (high blood levels of uric acid), pain in arms or legs, and anemia (low red blood cell counts). [3]

NEXLETOL® is a brand of bempedoic acid. It lowers the level of cholesterol in your blood. Cholesterol is a type of fat that helps your body perform many important functions. But too …

Bempedoic acid (brand name Nexletol) is an oral, non-statin, LDL cholesterol-lowering treatment that may be used in adults to: lower the risk of heart attack and heart procedures (for example stent placement or bypass surgery), in those unable to take recommended statin treatment (a cholesterol-lowering medicine), or are not taking a statin, who:

Sep 24, 2021 · NEXLETOL is indicated: To reduce the risk of myocardial infarction and coronary revascularization in adults who are unable to take recommended statin therapy (including those not taking a ...

NEXLETOL is indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or established...

NEXLIZET and NEXLETOL are the only nonstatins FDA approved to lower LDL-C and reduce the risk of MI and coronary revascularization in primary prevention and secondary prevention patients. 1,2